sod1

Tiomolibdate diammonium (NSC-286644) 是超氧化物歧化酶 1 (SOD1) 的抑制剂，具有抗血管生成和抗肿瘤活性。 Tiomolibdate diammonium 抑制铜酶的活性，包括 SOD1 和 COX。

ATN-224 (Bis(choline)tetrathiomolybdate) 抑制内皮细胞中的 SOD1 活性，这种作用呈剂量依赖性，IC50 为 17.5±3.7 nM。 ATN-224 是一种口服 Cu2+ Zn2+-超氧化物歧化酶 1 (SOD1) 抑制剂。

SOD1 (147-153) human是一段在Cu Zn超氧化物歧化酶 (SOD1) 中倾向于形成淀粉样蛋白纤维的肽段.此肽段促进聚集体的形成,是导致家族性肌萎缩侧索硬化症 (fALS) 和散发性肌萎缩侧索硬化症 (sALS) 的关键分子.

SOD1-Derlin-1 inhibitor-1 (SOD1-Derlin-1 Inhibitor 56-20) (compound 56-20) 是 SOD1-Derlin-1相互作用的抑制剂。SOD1-Derlin-1 inhibitor-1 抑制 SOD1G93A-Derlin-1 复合物，IC50值为 7.11 μM。SOD1-Derlin-1 inhibitor-1 可用于肌萎缩性侧索硬化症的研究。

SOD1-Derlin-1 Inhibitor 56-26 is a potent inhibitor of SOD1-Derlin-1 interaction.

SOD1-Derlin-1 inhibitor 56-59是SOD1-Dderin-1相互作用的抑制剂。SOD1-Derlin-1 inhibitor 56-59在肌萎缩侧索硬化症（ALS）研究中具有潜力。

Dimethyl sulfoxide (DMSO) 是一种常用的溶剂，可溶解极性和非极性化合物。Dimethyl sulfoxide 已被广泛用于生物实验中化合物的母液配制。Dimethyl sulfoxide 具有抑菌活性。

LCS-1 是一种选择性超氧化物歧化酶 1 (SOD1) 抑制剂，也是吡哒嗪-3-酮衍生物，在高浓度时显示出锥虫杀灭活性。LCS-1 抑制超氧化物歧化酶 1 诱导神经胶质瘤细胞的 ROS 依赖性死亡并降解 PARP 和 BRCA1。

ATN-224是铵盐型四硫代钼酸盐的第二代类似物，且为一种新型铜螯合剂。它通过抑制CuZn超氧化物歧化酶1（SOD1），展现出抗血管生成和抗肿瘤效果。

AKV-9 是一种突变型 Cu Zn 超氧化物歧化酶 (SOD1) 抑制剂，能够抑制 SOD1 诱导的蛋白质聚集，并在 PC-12 细胞中展现对 SOD1 诱导的细胞毒性的保护作用，EC50 为 0.3 μM。AKV-9 可在小鼠模型中改善肌萎缩侧索硬化症 (ALS)，并延长其寿命。

Diallyl tetrasulfide is an organosulfur compound that has been found in A. sativum and has diverse biological activities, including antimicrobial, antioxidant, and anticancer properties.[1],[2],[3],[4] It is active against the bacteria S. aureus and methicillin-resistant S. aureus (MRSA; MICs = 0.5 and 2 mg L, respectively), as well as the fungi C. albicans, C. krusei, C. glabrata, A. niger, A. flavus, and A. fumigatus (MICs = 0.5, 4, 2, 1, 2, and 4 mg L, respectively).[1] It reduces cadmium-induced increases in hepatic levels of thiobarbituric acid reactive substances (TBARS) and increases cadmium-induced decreases in the hepatic activity of superoxide dismutase (SOD1), catalase, GST, and glucose-6-phosphate dehydrogenase (G6PDH) in rats when administered at a dose of 40 mg kg.[2] Diallyl tetrasulfide is cytotoxic to MCF-7 breast cancer cells (IC50 = 92 μM) and reduces tumor growth in a BGC-823 mouse xenograft model when administered at doses of 20, 30, and 40 mg kg for 32 days.[3],[4]

The metallo-protein Cu/Zn-superoxide dismutase (SOD1) is a ubiquitous enzyme responsible for scavenging superoxide radicals. Mutations in SOD1, which alter its metal binding capacity and can result in protein misfolding and aggregation, have been linked to familial amyotrophic lateral sclerosis (ALS). Cu-ATSM is an orally bioavailable, blood-brain barrier permeable complex that has traditionally been used in cellular imaging experiments to selectively label hypoxic tissue via its susceptibility to reduction by oxygen-depleted mitochondria. More recently, Cu-ATSM has been reported to improve locomotor function and survival in a transgenic ALS mouse model by delivering copper specifically to cells in the spinal cords of mice producing misfolded SOD1 proteins. Copper chaperone for SOD (CCS) is presumed to utilize the copper from Cu-ATSM to prevent misfolding of the SOD1 protein.

CLR01 is a molecular tweezer. CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy. CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS. CLR01 inhibits Ebola and Zika virus infection. CLR01 Stabilizes a Disordered Protein-Protein Interface. CLR01, Modulates Aggregation of the Mutant p53 DNA Binding Domain and Inhibits Its Toxicity.

NUCC-0000323 是一种针对超氧化物歧化酶 1 (SOD1) 的有效抑制剂，能够抑制 SOD1 的表达。该化合物在肌萎缩侧索硬化症 (ALS) 研究中有潜在应用。

ROCK2-IN-5是一种复合型化合物，融合了Rho激酶抑制剂fasudil以及NRF2诱导剂咖啡酸和阿魏酸的结构元素。该化合物展示了优秀的多靶点作用特性和较高的耐受性。ROCK2-IN-5在针对SOD1基因变异型ALS研究中具备应用潜力。

CMB-087229为一种针对突变SOD1蛋白的聚集阻断剂，具有IC50值为67 nM，主要用于肌萎缩侧索硬化症的研究。

Fraxinellone analog 1 (compound 2) 作为一种Nrf2介导的抗氧化防御系统激活剂,显示出高效和迅速的效应,并对谷氨酸诱导的兴奋性毒性提供保护.它通过诱导Gpx4、Sod1和Nqo1等抗氧化基因的表达来发挥作用.此外,Fraxinellone analog 1 还具备神经保护特性,可调节抗氧化应激和炎症,适用于神经退行性疾病的相关研究.